References
- Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Parenti M. A., Rabini T., Tommasini R. New oral antidiabetic drugs, Part I. Arzneim-forsch 1971; 21: 2001. Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Parenti M. A., Rabini T., Tommasini R. New oral antidiabetic drugs, Part I. Arzneim-forsch 1971; 21: 200
- Ambrogi V., Bloch K., Cozzi P., Daturi S., Logemann W., Parenti M. A., Tommasini R. New oral antidiabetic drugs, Part II. Arzneim.-forsch 1971; 21: 2042. Ambrogi V., Bloch K., Cozzi P., Daturi S., Logemann W., Parenti M. A., Tommasini R. New oral antidiabetic drugs, Part II. Arzneim.-forsch 1971; 21: 204
- Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Mandelli V., Parenti M. A., Rabini T., Usardi M. M., Tommasini R. Pharmacological study on a new oral antidiabetic: N{ 4-[ß-(5-methyl-pyrazine-2-carboxamido)-ethyl]-benzene-sulphonyl }-N'-cyclohexyl-urea or K 4024. Arzneim.-forsch 1971; 21: 2083. Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Mandelli V., Parenti M. A., Rabini T., Usardi M. M., Tommasini R. Pharmacological study on a new oral antidiabetic: N{ 4-[ß-(5-methyl-pyrazine-2-carboxamido)-ethyl]-benzene-sulphonyl }-N'-cyclohexyl-urea or K 4024. Arzneim.-forsch 1971; 21: 208
- Marigo S., delNovo G., Bini P. P., Sacchetti G. Pharmacological methods for evaluating a new hypoglycaemic agent in humans: a multistep design. Arzneim-forsch 1971; 21: 2154. Marigo S., delNovo G., Bini P. P., Sacchetti G. Pharmacological methods for evaluating a new hypoglycaemic agent in humans: a multistep design. Arzneim-forsch 1971; 21: 215
- Pedrazzi F., Pisani Ceretti A., Losi S., Bommartini F., Artini D., Emanueli A. Evaluation in hospitalized subjects of a new hypoglycaemic sulphonylurea, glyziadinamide. Arzneim.-forsch 1971; 21: 2205. Pedrazzi F., Pisani Ceretti A., Losi S., Bommartini F., Artini D., Emanueli A. Evaluation in hospitalized subjects of a new hypoglycaemic sulphonylurea, glyziadinamide. Arzneim.-forsch 1971; 21: 220